SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-027061
Filing Date
2023-08-07
Accepted
2023-08-07 17:25:41
Documents
1
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4143
  Complete submission text file 0001493152-23-027061.txt   5624
Mailing Address C/O JAGUAR ANIMAL HEALTH, INC. 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address
Waltzman Roger J. (Reporting) CIK: 0001678987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 231148609

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations